BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
OYLER JOHN | Chief Executive Officer | Oct 08 '24 | Sale | 232.22 | 10,000 | 2,322,161 | 0 | Oct 10 05:48 PM | OYLER JOHN | Chief Executive Officer | Oct 08 '24 | Sale | 232.22 | 6,175 | 1,433,931 | 0 | Oct 10 05:48 PM | JOHN F OYLER | Director | Oct 08 '24 | Proposed Sale | 243.02 | 6,175 | 1,500,648 | | Oct 08 04:24 PM | OYLER INVESTMENT LLC | Director | Oct 08 '24 | Proposed Sale | 243.02 | 10,000 | 2,430,200 | | Oct 08 04:23 PM | Lee Chan Henry | SVP, General Counsel | Sep 30 '24 | Sale | 237.10 | 1,202 | 284,994 | 0 | Oct 02 07:13 PM | Wang Lai | Global Head of R&D | Sep 27 '24 | Sale | 220.35 | 5,000 | 1,101,774 | 0 | Oct 01 06:29 PM | CHAN LEE | Officer | Sep 30 '24 | Proposed Sale | 218.42 | 1,202 | 262,541 | | Sep 30 04:27 PM | WANG HOLDINGS LLC | Officer | Sep 27 '24 | Proposed Sale | 212.53 | 5,000 | 1,062,650 | | Sep 27 04:25 PM | Wu Xiaobin | President, COO & GM China | Sep 19 '24 | Sale | 200.14 | 4,500 | 900,615 | 0 | Sep 19 05:25 PM | Wu Xiaobin | President, COO & GM China | Sep 17 '24 | Sale | 200.00 | 500 | 100,000 | 4,500 | Sep 19 05:25 PM | XIAOBIN WU | Officer | Sep 17 '24 | Proposed Sale | 196.45 | 5,000 | 982,250 | | Sep 17 04:40 PM | Wu Xiaobin | President, COO & GM China | Sep 03 '24 | Sale | 189.65 | 5,556 | 1,053,677 | 0 | Sep 05 05:41 PM | Ball Titus B. | Principal Accounting Officer | Sep 03 '24 | Sale | 189.94 | 137 | 26,022 | 0 | Sep 05 05:40 PM | AIJUN WANG | Officer | Sep 03 '24 | Proposed Sale | 190.08 | 3,160 | 600,661 | | Sep 03 05:00 PM | XIAOBIN WU | Officer | Sep 03 '24 | Proposed Sale | 191.78 | 5,556 | 1,065,530 | | Sep 03 04:19 PM | PAN-OYLER FOUNDATION | Director | Aug 27 '24 | Proposed Sale | 199.22 | 1,883 | 375,131 | | Aug 27 04:30 PM | Lee Chan Henry | SVP, General Counsel | Jul 30 '24 | Sale | 160.57 | 834 | 133,915 | 0 | Aug 01 05:06 PM | CHAN LEE | Officer | Jul 30 '24 | Proposed Sale | 160.57 | 834 | 133,915 | | Jul 30 04:15 PM | Wang Julia Aijun | Chief Financial Officer | Jul 01 '24 | Sale | 143.90 | 472 | 67,919 | 0 | Jul 03 05:05 PM | Wang Julia Aijun | Chief Financial Officer | Jun 24 '24 | Sale | 155.66 | 899 | 139,938 | 0 | Jun 26 05:26 PM | Wang Lai | Global Head of R&D | Jun 24 '24 | Sale | 159.80 | 1,064 | 170,030 | 0 | Jun 26 05:25 PM | Wu Xiaobin | President, COO & GM China | Jun 24 '24 | Sale | 159.79 | 1,459 | 233,133 | 0 | Jun 26 05:24 PM | OYLER JOHN | Chief Executive Officer | Jun 24 '24 | Sale | 159.58 | 2,789 | 445,070 | 0 | Jun 26 05:22 PM | OYLER JOHN | Chief Executive Officer | Jun 17 '24 | Sale | 159.35 | 1,281 | 204,125 | 0 | Jun 20 05:27 PM | Wang Julia Aijun | Chief Financial Officer | Jun 17 '24 | Sale | 159.04 | 916 | 145,678 | 0 | Jun 20 05:26 PM | Wang Lai | Global Head of R&D | Jun 17 '24 | Sale | 159.24 | 1,500 | 238,857 | 841 | Jun 20 05:25 PM | Wang Lai | Global Head of R&D | Jun 18 '24 | Sale | 153.75 | 841 | 129,305 | 0 | Jun 20 05:25 PM | Wu Xiaobin | President, COO & GM China | Jun 18 '24 | Sale | 154.36 | 2,627 | 405,516 | 0 | Jun 20 05:25 PM | Wu Xiaobin | President, COO & GM China | Jun 17 '24 | Sale | 159.00 | 627 | 99,692 | 2,627 | Jun 20 05:25 PM | Lee Chan Henry | SVP, General Counsel | Jun 17 '24 | Sale | 159.35 | 439 | 69,955 | 0 | Jun 20 05:24 PM | OYLER JOHN | Chief Executive Officer | Apr 10 '24 | Sale | 148.89 | 26,716 | 3,977,861 | 12,084 | Apr 11 06:01 PM | OYLER JOHN | Chief Executive Officer | Apr 11 '24 | Sale | 146.73 | 12,084 | 1,773,085 | 0 | Apr 11 06:01 PM | OYLER JOHN | Chief Executive Officer | Apr 09 '24 | Sale | 153.94 | 11,200 | 1,724,078 | 38,800 | Apr 11 06:01 PM | OYLER JOHN | Chief Executive Officer | Mar 12 '24 | Sale | 164.02 | 37,668 | 6,178,369 | 12,332 | Mar 14 05:23 PM | OYLER JOHN | Chief Executive Officer | Mar 13 '24 | Sale | 177.56 | 12,332 | 2,189,648 | 0 | Mar 14 05:23 PM | Wang Julia Aijun | Chief Financial Officer | Feb 29 '24 | Sale | 167.08 | 397 | 66,331 | 0 | Mar 04 05:22 PM |
|